|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-4.03/0.61
|
企業價值
807.33M
|
資產負債 |
每股賬面淨值
9.80
|
現金流量 |
現金流量率
0.02
|
損益表 |
收益
157.75M
|
每股收益
9.75
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/16 21:31 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19. |